Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
294,683,714
-
Number of holders
-
178
-
Total 13F shares, excl. options
-
79,874,675
-
Shares change
-
+17,352,985
-
Total reported value, excl. options
-
$860,158,811
-
Value change
-
+$188,076,135
-
Put/Call ratio
-
66%
-
Number of buys
-
106
-
Number of sells
-
65
-
Price
-
$10.77
Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q2 2019
As of 30 Jun 2019 SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) had 178 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 79,874,675 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, WASATCH ADVISORS INC, STATE STREET CORP, Bellevue Group AG, FMR LLC, CREDIT SUISSE AG/, DIMENSIONAL FUND ADVISORS LP, and CITADEL ADVISORS LLC.
This table shows 178 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.